Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Ringborg

Showing results (121-130 of 158) with videos related to

Pageof 16
Sort By:
Cancer|October 1, 1983
Epstein-Barr virus-specific serodiagnostic tests in carcinomas of the head and neckU Ringborg, W Henle, G Henle, et al.
Cancer|May 1, 1994
Prognostic factors in thin cutaneous malignant melanomaE Månsson-Brahme, J Carstensen, K Erhardt, et al.
Preventive Medicine|March 1, 1996
Perceived susceptibility to and knowledge of malignant melanoma: screening participants vs the general populationY Brandberg, C Bolund, H Michelson, et al.
Anticancer Research|July 1, 1997
Prognostic value of serum analyses of S-100 protein beta in malignant melanomaL O Hansson, E von Schoultz, E Djureen, et al.
Carcinogenesis|January 1, 1994
Cell cycle dependent sensitivity of human melanoma cells to melphalan is correlated with the activity and cellular concentration of glutathione transferasesU Jungnelius, X Y Hao, S Skog, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Psychological reactions in public melanoma screeningY Brandberg, C Bolund, H Michelson, et al.
Ophthalmology|October 1, 1995
Prevalence of primary acquired melanosis and nevi of the conjunctiva and uvea in the dysplastic nevus syndrome. A case-control studyS Seregard, E af Trampe, E Månsson-Brahme, et al.
Acta Oncologica (Stockholm, Sweden)|November 27, 1998
Central nervous system metastases of cutaneous malignant melanoma--a population-based studyG Cohn-Cedermark, E Månsson-Brahme, L E Rutqvist, et al.
Cancer|August 5, 2000
Trends in mortality from malignant melanoma in Sweden, 1970-1996G Cohn-Cedermark, E Månsson-Brahme, L E Rutqvist, et al.
Acta Oncologica (Stockholm, Sweden)|July 31, 1999
Metastatic patterns, clinical outcome, and malignant phenotype in malignant cutaneous melanomaG Cohn-Cedermark, E Månsson-Brahme, L E Rutqvist, et al.
Pageof 16

Showing results (121-130 of 158) with videos related to

Sort By:
Pageof 16
Cancer|October 1, 1983
Epstein-Barr virus-specific serodiagnostic tests in carcinomas of the head and neckU Ringborg, W Henle, G Henle, et al.
Cancer|May 1, 1994
Prognostic factors in thin cutaneous malignant melanomaE Månsson-Brahme, J Carstensen, K Erhardt, et al.
Preventive Medicine|March 1, 1996
Perceived susceptibility to and knowledge of malignant melanoma: screening participants vs the general populationY Brandberg, C Bolund, H Michelson, et al.
Anticancer Research|July 1, 1997
Prognostic value of serum analyses of S-100 protein beta in malignant melanomaL O Hansson, E von Schoultz, E Djureen, et al.
Carcinogenesis|January 1, 1994
Cell cycle dependent sensitivity of human melanoma cells to melphalan is correlated with the activity and cellular concentration of glutathione transferasesU Jungnelius, X Y Hao, S Skog, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Psychological reactions in public melanoma screeningY Brandberg, C Bolund, H Michelson, et al.
Ophthalmology|October 1, 1995
Prevalence of primary acquired melanosis and nevi of the conjunctiva and uvea in the dysplastic nevus syndrome. A case-control studyS Seregard, E af Trampe, E Månsson-Brahme, et al.
Acta Oncologica (Stockholm, Sweden)|November 27, 1998
Central nervous system metastases of cutaneous malignant melanoma--a population-based studyG Cohn-Cedermark, E Månsson-Brahme, L E Rutqvist, et al.
Cancer|August 5, 2000
Trends in mortality from malignant melanoma in Sweden, 1970-1996G Cohn-Cedermark, E Månsson-Brahme, L E Rutqvist, et al.
Acta Oncologica (Stockholm, Sweden)|July 31, 1999
Metastatic patterns, clinical outcome, and malignant phenotype in malignant cutaneous melanomaG Cohn-Cedermark, E Månsson-Brahme, L E Rutqvist, et al.
Pageof 16